Novel MRI contrast agent for molecular imaging of fibrin implications for detecting vulnerable plaques

Circulation

Volumn 104, Issue 11, 2001, Pages 1280-1285

  Flacke, Sebastian ^a   Fischer, Stefan ^b   Scott, Michael J ^c   Fuhrhop, Ralph J ^c   Allen, John S ^c   McLean, Mark ^c   Winter, Patrick ^c   Sicard, Gregorio A ^c   Gaffney, Patrick J ^d   Wickline, Samuel A ^c   Lanza, Gregory M ^c  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPS HEALTHCARE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Contrast media; Fibrin; Magnetic resonance imaging; Plaque

Indexed keywords

CONTRAST MEDIUM; FIBRIN; FLUOROCARBON; GADOLINIUM PENTETATE; LIPID; NANOPARTICLE; OLEIC ACID; PHOSPHATIDYLETHANOLAMINE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; DRUG FORMULATION; DRUG SPECIFICITY; FIBRIN CLOT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SIGNAL NOISE RATIO; THROMBUS;

EID: 0035845635     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3601.094303     Document Type: Article

References (30)

1. Present status of coronary artery disease
2. Plaque fissures in human coronary thrombosis
3. Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion dufing intracoronary infusion of streptokinase for acute myocardial infarction: Quantitative angiographic observations
4. Angiographic progression of coronary artery disease and the development of myocardial infarction
5. Compensatory enlargement of human atherosclerotic coronary arteries
6. Characterization of plaque components and vulnerability with intravascular ultrasound elastography
7. Current status of radionuclide tracer imaging of thrombi and atheroma
8. Thermal detection of cellular infiltrates in living atherosclerotic plaques: Possible implications for plaque rupture and thrombosis
9. Direct magnetic resonance imaging of carotid artery thrombus in acute stroke
10. Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo
11. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo
12. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging
13. Characterization of atherosclerotic plaques by magnetic resonance imaging
14. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging
15. In vivo efficacy of fibrin targeted perfluorocarbon contrast system following intravenous injection reflects prolonged systemic half-life and persistent acoustic contrast effect
16. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent
17. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent
18. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles
19. A novel site-targeted ultrasonic contrast agent with broad biomedical application
20. Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound
21. Evaluation of fibrin binding profile of two antifibrin monoclonal antibodies
22. Time saving in measurement of NMR and EPR relaxation times
23. Measurement of signal intensities in the presence of noise in MR images
24. Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: Coronary angiographic findings within 1 week before the onset of infarction
25. Targeted contrast agents in MR imaging
26. Molecular characterization of thrombus using bimodal 1H/19F MR imaging with a novel fibrin-targeted nano-particulate contrast agent
27. Molecular imaging: Exploring the next frontier
28. MS-325: Albumin-targeted contrast agent for MR angiography
29. A liposomal MRI contrast agent: Phosphatidylethanolamine-DTPA
30. Relaxivities of paramagnetic nano-particle contrast agents for targeted molecular imaging